Effects of Trimetazidine Pretreatment on Endothelial Dysfunction and Myocardial Injury in Unstable Angina Patients Undergoing Percutaneous Coronary Intervention

OBJECTIVES: Trimetazidine is an anti-ischemic medication licensed for the treatment of angina pectoris. However, the molecular mechanisms underlying its action remain incompletely elucidated. In this study, therefore, we examined the potential beneficial effects of trimetazidine on myocardial injury...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Shuai, Shi, Zhaozhao, Tse, Gary, Wang, Xinghua, Ni, Yanping, Liu, Hongmei, Liu, Tong, Li, Guangping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745110/
https://www.ncbi.nlm.nih.gov/pubmed/31565429
http://dx.doi.org/10.1155/2019/4230948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745110/
https://www.ncbi.nlm.nih.gov/pubmed/31565429
http://dx.doi.org/10.1155/2019/4230948

Ejemplares similares